| 1. |
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
- Munthe, Christian, 1962
(författare)
-
Den bedrägliga anti-antropokausismen
- 2001
-
Ingår i: Sjöberg, F (ed.), Vad ska vi med naturen till?. - Nora : Nya Doxa. - 9157803714 ; , s. 41-46
-
Bokkapitel (övrigt vetenskapligt/konstnärligt)
|
|
| 5. |
- Munthe, Christian, 1962
(författare)
-
Det kostar att vara försiktig
- 2004
-
Ingår i: Forskning och Framsteg. ; :38
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
|
|
| 6. |
- Munthe, Christian, 1962
(författare)
-
Divisibility and the Moral Status of Embryos
- 2001
-
Ingår i: Bioethics. ; 15:5/6, s. 382-397
-
Tidskriftsartikel (refereegranskat)abstract
- The phenomenon of twinning in early fetal development has become a popular source for doubt regarding the ascription of moral status to early embryos. In this paper, the possible moral basis for such a line of reasoning is critically analysed with sceptical results. Three different versions of the argument from twinning are considered, all of which are found to rest on confusions between the actual division of embryos involed in twinning and the property of early embryos to be divisible, be based on highly questionable ethical assumptions, or to imply inconsistent claims regarding the moral importance of potentiality and/or the moral status of embryos. This is taken to expose a number of related inconsistencies in the moral basis of pro-life positions. In particular, ascribing moral significance to the property of being (in)divisible is found to be incompatible with the claim that human individuals possess unique values which could underpin an absolute moral ban on murder.
|
|
| 7. |
- Munthe, Christian, 1962
(författare)
-
Ethical Aspects of Controlling Genetic Doping
- 2003
-
Ingår i: Gene Technology in Elite Sports, University of Sports, Stockholm, 22-23 may 2003.
-
Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
- ABSTRACT The IOC and WADA have announced their ambition to develop control program in order to detect athletes' illegitimate use of genetic technology for enhancing performance. Although it is far from clear what such uses should be counted as illegitimate, as well as to what extent the idea of control programs for such things is a feasible idea, I will assume that such programs will concern so-called somatic genetic modifications that aims at altering the athlete's initial bodily biochemistry in a way that may enhance performance without the presence of any medical reason for undertaking such modifications. This means that the envisioned control-program will have to make use of the method of genetic testing in order to detect the possible presence (or non-presence) of various genetic variants within the athlete. As a consequence of this, several ethical issues familiar within the field of genetic testing for health purposes are suddenly actualised within the area of doping control. These issues concern primarily how to handle and communicate the information about the athlete that is uncovered by such testing. However, due to the ways in which gene doping may be performed, in the case of athletic control programs, issues of medical safety and the question of what hardships it is reasonable to require of athletes to endure also become paramount. As a consequence, one may ask whether or not sporting ethics will have to consider applying the rule of informed consent in connection to testing programs of the kind here discussed.
|
|
| 8. |
|
|
| 9. |
- Munthe, Christian, 1962
(författare)
-
Etiska aspekter på regenerativ medicin : Ethical aspects on regenerative medicine
- 2003
-
Ingår i: SNIB-konferensen 2003, Chalmers tekniska högskola, Göteborg, 16-18 maj 2003.
-
Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
- Inom den regenerativa medicinen strävar man efter att ersätta skadat eller sjukligt biologiskt mänskligt material (celler, organ, kroppsdelar) med nya biologiska komponenter. Området aktualiserar en rad etiska frågeställningar vad gäller (1) produktionen av ersättningsmaterialet (t.ex. embryonala stamceller eller införskaffande av transplantationsvävnad från donatorer), (2) risker i samband med försök på människa (genmodifierat material, material från djur), samt (3) gränserna för hur långt man bör gå i denna slags försök att förlänga människans livsspann. Föredraget ger en kort översikt över dessa frågeställningar, ståndpunkter och argument i debatten kring dem.
|
|
| 10. |
|
|
